Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11961432 | 0.85 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2TSHRGAAMEN1 | |
| SCHEMBL9611933 | 0.83 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2LMNAHPGDMAPT | |
| SCHEMBL9247606 | 0.83 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2LMNAHPGDMAPT | |
| SCHEMBL16090421 | 0.83 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2LMNAHPGDMAPT | |
| SCHEMBL11043305 | 0.81 | ALDH1A1 (0.55) | ALDH1A1SMN1; SMN2TSHRGAAMEN1 | |
| SCHEMBL11419655 | 0.81 | GAA (0.51) | ALDH1A1SMN1; SMN2TSHRGAAMEN1 | |
| SCHEMBL28371429 | 0.80 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2TSHRGAAMEN1 | |
| SCHEMBL11038920 | 0.80 | LMNA (0.46) | ALDH1A1SMN1; SMN2TSHRGAAMEN1 | |
| SCHEMBL21987044 | 0.80 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL20919927 | 0.80 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6759170-B2 | Organic carbonate additives for nonaqueous electrolyte rechargeable electrochemical cells | WILSON GREATBATCH TECHNOLOGIES, INC. | 2004-07-06 | — | — | US | claimed |
| US-6605385-B2 | Carbonate compound has bonds of specified dissociation energy, such as dibenzyl carbonate, mixed with either the anode or the cathode active material prior to contact with its current collectors; use in defibrillators | WILSON GREATBATCH LTD. | 2003-08-12 | — | — | US | claimed |
| US-20030129500-A1 | Organic carbonate additives for nonaqueous electrolyte rechargeable electrochemical cells | GREATBATCH, INC. | 2003-07-10 | — | — | US | claimed |
| US-20020136951-A1 | Electrochemical cell having an electrode with a carbonate additive in the electrode active mixture | GREATBATCH, INC. | 2002-09-26 | — | — | US | claimed |
| EP-1244160-A1 | Electrochemical cell having an electrode with a carbonate additive in the electrode active mixture | Wilson Greatbatch Limited (US) | 2002-09-25 | — | — | EP | claimed |
| EP-1215746-A1 | Organic carbonate additives for nonaqueous electrolyte rechargeable electrochemical cells | WILSON GREATBATCH LTD. (US) | 2002-06-19 | — | — | EP | claimed |
| EP-0803924-B1 | Organic carbonate additives for nonaqueous electrolyte in alkali metal electrochemical cells | GREATBATCH W LTD (US) | 2001-10-31 | — | — | EP | claimed |
| US-20010004507-A1 | Organic carbonate additives for nonaqueous electrolyte rechargeable electrochemical cells | GREATBATCH LTD. | 2001-06-21 | — | — | US | claimed |
| US-6221534-B1 | CATHODE IS INORGANIC REACTION PRODUCT CONTAINING VANADIUM OXIDE AND SILVER OXIDE | WILSON GREATBATCH LTD. | 2001-04-24 | — | — | US | claimed |
| EP-1005098-A2 | Alkali metal electrochemical cell having an improved cathode activated with a nonaqueous electrolyte having a passivation inhibitor additive | WILSON GREATBATCH LTD. (US) | 2000-05-31 | — | — | EP | claimed |
| EP-0996187-A1 | Organic carbonate additives for nonaqueous electrolyte rechargeable cells | WILSON GREATBATCH LTD. (US) | 2000-04-26 | — | — | EP | claimed |
| US-5753389-A | Organic carbonate additives for nonaqueous electrolyte in alkali metal electrochemical cells | WILSON GREATBATCH LTD. (US) | 1998-05-19 | — | — | US | claimed |
| EP-0803924-A2 | Organic carbonate additives for nonaqueous electrolyte in alkali metal electrochemical cells | WILSON GREATBATCH LTD. (US) | 1997-10-29 | — | — | EP | claimed |
| JP-61036261-A | — | — | None | — | — | JP | disclosed |
| EP-3891162-B1 | NOVEL DERIVATIVES OF N-3\"-GUANIDINO-2,5-DIDEOXY-5-FLUORO-4,6-DISUBSTITUTED-STREPTAMINE AMINOGLYCOSIDE ANTIBIOTICS | AGILEBIOTICS B V (NL) | 2024-03-06 | — | — | EP | disclosed |
| US-20220127297-A1 | Novel Antibacterial 3\"-Derivatives Of 4,6-Disubstituted 2,5-Dideoxystreptamine Aminoglycoside Antibiotics | AGILEBIOTICS B.V. (NL) | 2022-04-28 | — | — | US | disclosed |
| EP-0083923-A2 | Aminoacyl-containing dipeptide derivatives useful as antihypertensives | MERCK & CO. INC. (US) | 1983-07-20 | — | — | EP | disclosed |
| US-4219644-A | Fortimicins AH and AI | ABBOTT LABORATORIES (US) | 1980-08-26 | — | — | US | disclosed |
| US-4213972-A | BACTERICIDES | ABBOTT LABORATORIES (US) | 1980-07-22 | — | — | US | disclosed |
| US-4181797-A | 1-N-(ω-amino-α-hydroxyalkanoyl) derivatives of 4'-deoxy-6'-N-methylkanamycin A | BRISTOL-MYERS COMPANY (US) | 1980-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127297-A1 | Novel Antibacterial 3\"-Derivatives Of 4,6-Disubstituted 2,5-Dideoxystreptamine Aminoglycoside Antibiotics | ABCC1, AMPD3, MRPS35 | ALDH1A1 2961/4885SMN1; SMN2 4353/4885TSHR 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.